Loeb's Third Point Shows A Number of New Positions in Latest 13F
Third Point LLC, run by activist investors Daniel Loeb, released its 13F for the quarter ended March 31, 2007 yesterday afternoon.
Some interesting new positions from the filing:
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) 350,000 shares
Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) 400,000 shares
Alkermes, Inc. (Nasdaq: ALKS) 750,000 shares
Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) 1,600,000 shares
ATP Oil & Gas Corp. (Nasdaq: ATPG) 2,000,000 shares (already known from 13G)
BearingPoint (NYSE: BE) 3,000,000 shares
Burlington Northern Santa Fe Corp. (NYSE: BNI) 325,000 shares
Candela Corp. (Nasdaq: CLZR) 1,275,000 shares (already known from 13D)
Charming Shoppes Inc. (Nasdaq: CHRS) 2,200,000 shares
Coleman Cable, Inc. (Nasdaq: CCIX) 666,667 shares
CV Therapeutics, Inc. (Nasdaq: CVTX) 1,350,000 shares
DepoMed Inc. (Nasdaq: DEPO) 325,000 shares (already known from 13G)
FMC Corp. (NYSE: FMC) 700,000 shares
General Motors Corporation (NYSE: GM) 1,000,000 shares
Granite Construction Inc. (NYSE: GVA) 1,350,000 shares (already known from 13D)
Kansas City Southern (NYSE: KSU) 2,000,000 shares
MDS, Inc. (NYSE: MDZ) 1,350,000 shares
Norfolk Southern Corp. (NYSE: NSC) 1,250,000
Northern Orion Resources Inc. (AMEX: NTO) 7,600,000 shares
Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) 1,080,000 shares
Talisman Energy Inc. (NYSE: TLM) 3,750,000 shares
Tronox Inc. (NYSE: TRX) 900,000 shares
Some interesting new positions from the filing:
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) 350,000 shares
Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) 400,000 shares
Alkermes, Inc. (Nasdaq: ALKS) 750,000 shares
Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) 1,600,000 shares
ATP Oil & Gas Corp. (Nasdaq: ATPG) 2,000,000 shares (already known from 13G)
BearingPoint (NYSE: BE) 3,000,000 shares
Burlington Northern Santa Fe Corp. (NYSE: BNI) 325,000 shares
Candela Corp. (Nasdaq: CLZR) 1,275,000 shares (already known from 13D)
Charming Shoppes Inc. (Nasdaq: CHRS) 2,200,000 shares
Coleman Cable, Inc. (Nasdaq: CCIX) 666,667 shares
CV Therapeutics, Inc. (Nasdaq: CVTX) 1,350,000 shares
DepoMed Inc. (Nasdaq: DEPO) 325,000 shares (already known from 13G)
FMC Corp. (NYSE: FMC) 700,000 shares
General Motors Corporation (NYSE: GM) 1,000,000 shares
Granite Construction Inc. (NYSE: GVA) 1,350,000 shares (already known from 13D)
Kansas City Southern (NYSE: KSU) 2,000,000 shares
MDS, Inc. (NYSE: MDZ) 1,350,000 shares
Norfolk Southern Corp. (NYSE: NSC) 1,250,000
Northern Orion Resources Inc. (AMEX: NTO) 7,600,000 shares
Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) 1,080,000 shares
Talisman Energy Inc. (NYSE: TLM) 3,750,000 shares
Tronox Inc. (NYSE: TRX) 900,000 shares
Labels: Daniel Loeb, Third Point LLC
0 Comments:
Post a Comment
<< Home